| Code | Description | Claims | Beneficiaries | Total Paid |
| 99214 |
|
83,097 |
72,606 |
$880K |
| G6015 |
Intensity modulated treatment delivery, single or multiple fields/arcs,via narrow spatially and temporally modulated beams, binary, dynamic mlc, per treatment session |
15,978 |
3,588 |
$733K |
| J2505 |
Injection, pegfilgrastim, 6 mg |
1,878 |
1,413 |
$616K |
| J1439 |
Injection, ferric carboxymaltose, 1 mg |
8,269 |
6,321 |
$509K |
| 78815 |
|
3,870 |
3,557 |
$498K |
| 96413 |
|
26,512 |
18,263 |
$374K |
| J0881 |
Injection, darbepoetin alfa, 1 microgram (non-esrd use) |
4,611 |
3,956 |
$352K |
| J0897 |
Injection, denosumab, 1 mg |
1,681 |
1,626 |
$344K |
| J9035 |
Injection, bevacizumab, 10 mg |
394 |
231 |
$279K |
| 99213 |
|
30,440 |
28,370 |
$243K |
| 96367 |
|
21,003 |
13,999 |
$226K |
| 96372 |
|
50,302 |
38,961 |
$201K |
| 99215 |
Prolong outpt/office vis |
14,663 |
12,957 |
$168K |
| 85025 |
|
96,247 |
74,637 |
$150K |
| A9552 |
Fluorodeoxyglucose f-18 fdg, diagnostic, per study dose, up to 45 millicuries |
3,943 |
3,915 |
$147K |
| 77014 |
|
7,837 |
2,026 |
$140K |
| G6002 |
Stereoscopic x-ray guidance for localization of target volume for the delivery of radiation therapy |
7,772 |
1,865 |
$122K |
| J9022 |
Injection, atezolizumab, 10 mg |
135 |
102 |
$121K |
| 77301 |
|
297 |
155 |
$116K |
| 96365 |
|
17,357 |
13,322 |
$109K |
| Q5118 |
Injection, bevacizumab-bvzr, biosimilar, (zirabev), 10 mg |
418 |
222 |
$98K |
| Q5127 |
Injection, pegfilgrastim-fpgk (stimufend), biosimilar, 0.5 mg |
202 |
170 |
$78K |
| 80053 |
|
62,325 |
53,487 |
$70K |
| 99204 |
|
2,240 |
2,231 |
$66K |
| 99205 |
Prolong outpt/office vis |
4,208 |
4,132 |
$51K |
| Q5107 |
Injection, bevacizumab-awwb, biosimilar, (mvasi), 10 mg |
217 |
121 |
$48K |
| J0185 |
Injection, aprepitant, 1 mg |
1,295 |
961 |
$41K |
| J1449 |
Injection, eflapegrastim-xnst, 0.1 mg |
169 |
148 |
$35K |
| J1453 |
Injection, fosaprepitant, 1 mg |
1,726 |
1,208 |
$33K |
| J9355 |
Injection, trastuzumab, excludes biosimilar, 10 mg |
44 |
24 |
$32K |
| J1100 |
Injection, dexamethasone sodium phosphate, 1 mg |
13,646 |
8,705 |
$31K |
| 77427 |
|
2,168 |
1,153 |
$28K |
| 96375 |
|
6,177 |
4,064 |
$27K |
| 74177 |
|
1,386 |
1,306 |
$26K |
| J2506 |
Injection, pegfilgrastim, excludes biosimilar, 0.5 mg |
48 |
41 |
$25K |
| J2469 |
Injection, palonosetron hcl, 25 mcg |
4,691 |
2,971 |
$24K |
| J9271 |
Injection, pembrolizumab, 1 mg |
84 |
70 |
$24K |
| 96417 |
|
5,873 |
4,157 |
$22K |
| 82728 |
|
25,154 |
24,568 |
$22K |
| J1200 |
Injection, diphenhydramine hcl, up to 50 mg |
5,476 |
3,913 |
$21K |
| J1627 |
Injection, granisetron, extended-release, 0.1 mg |
497 |
337 |
$19K |
| 51798 |
|
453 |
428 |
$17K |
| 77336 |
|
2,467 |
1,409 |
$17K |
| 71260 |
|
1,019 |
953 |
$15K |
| J3420 |
Injection, vitamin b-12 cyanocobalamin, up to 1000 mcg |
14,503 |
12,532 |
$14K |
| 83550 |
|
26,016 |
25,410 |
$14K |
| 77334 |
|
735 |
601 |
$13K |
| 83540 |
|
26,053 |
25,441 |
$12K |
| 96377 |
|
1,033 |
830 |
$12K |
| J9264 |
Injection, paclitaxel protein-bound particles, 1 mg |
79 |
38 |
$11K |
| 96415 |
|
3,091 |
2,277 |
$10K |
| J1071 |
Injection, testosterone cypionate, 1 mg |
849 |
674 |
$10K |
| Q0138 |
Injection, ferumoxytol, for treatment of iron deficiency anemia, 1 mg (non-esrd use) |
644 |
506 |
$9K |
| J0640 |
Injection, leucovorin calcium, per 50 mg |
1,550 |
867 |
$8K |
| Q5111 |
Injection, pegfilgrastim-cbqv (udenyca), biosimilar, 0.5 mg |
38 |
30 |
$8K |
| 36415 |
|
27,122 |
23,600 |
$8K |
| 77300 |
|
413 |
383 |
$7K |
| J1454 |
Injection, fosnetupitant 235 mg and palonosetron 0.25 mg |
189 |
135 |
$7K |
| 99233 |
Prolong inpt eval add15 m |
2,113 |
729 |
$7K |
| 82378 |
|
5,774 |
5,057 |
$6K |
| 99212 |
|
444 |
423 |
$6K |
| Q5106 |
Injection, epoetin alfa-epbx, biosimilar, (retacrit) (for non-esrd use), 1000 units |
402 |
284 |
$6K |
| 96366 |
|
636 |
423 |
$6K |
| Q5122 |
Injection, pegfilgrastim-apgf (nyvepria), biosimilar, 0.5 mg |
17 |
14 |
$5K |
| Q5116 |
Injection, trastuzumab-qyyp, biosimilar, (trazimera), 10 mg |
18 |
12 |
$5K |
| 84443 |
|
4,121 |
4,040 |
$5K |
| J1642 |
Injection, heparin sodium, (heparin lock flush), per 10 units |
1,181 |
769 |
$5K |
| J1437 |
Injection, ferric derisomaltose, 10 mg |
35 |
34 |
$5K |
| 82306 |
|
2,989 |
2,973 |
$5K |
| J9299 |
Injection, nivolumab, 1 mg |
18 |
14 |
$4K |
| J9263 |
Injection, oxaliplatin, 0.5 mg |
655 |
384 |
$4K |
| 82607 |
|
6,917 |
6,858 |
$4K |
| 82746 |
|
4,956 |
4,938 |
$4K |
| J9190 |
Injection, fluorouracil, 500 mg |
1,789 |
966 |
$4K |
| Q9967 |
Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml |
2,850 |
2,830 |
$4K |
| 99203 |
|
76 |
76 |
$4K |
| 96416 |
|
883 |
507 |
$3K |
| 83615 |
|
7,188 |
6,533 |
$3K |
| 96523 |
|
278 |
219 |
$3K |
| 88185 |
|
135 |
130 |
$3K |
| 86300 |
|
2,103 |
1,903 |
$3K |
| 82664 |
|
1,513 |
1,493 |
$3K |
| J0885 |
Injection, epoetin alfa, (for non-esrd use), 1000 units |
25 |
12 |
$2K |
| Q5101 |
Injection, filgrastim-sndz, biosimilar, (zarxio), 1 microgram |
740 |
149 |
$2K |
| 80048 |
|
3,161 |
2,939 |
$2K |
| 99223 |
Prolong inpt eval add15 m |
27 |
26 |
$2K |
| 77338 |
|
60 |
56 |
$2K |
| 77263 |
|
90 |
88 |
$2K |
| 96411 |
|
808 |
510 |
$2K |
| J9045 |
Injection, carboplatin, 50 mg |
552 |
414 |
$2K |
| 77290 |
|
82 |
77 |
$2K |
| 81002 |
|
1,919 |
1,674 |
$1K |
| 96368 |
|
788 |
513 |
$1K |
| 99232 |
|
326 |
117 |
$1K |
| G6013 |
Radiation treatment delivery,3 or more separate treatment areas, custom blocking, tangential ports, wedges, rotational beam, compensators, electron beam; 11-19 mev |
117 |
25 |
$1K |
| 85045 |
|
3,504 |
3,446 |
$1K |
| 82232 |
|
571 |
549 |
$1K |
| 86304 |
|
1,011 |
831 |
$841.00 |
| 99426 |
|
206 |
205 |
$730.37 |
| 99222 |
|
15 |
15 |
$672.99 |
| 96361 |
|
848 |
469 |
$670.72 |
| 83735 |
|
1,930 |
1,589 |
$623.87 |
| J7030 |
Infusion, normal saline solution , 1000 cc |
590 |
309 |
$593.00 |
| 82784 |
|
1,115 |
1,094 |
$592.21 |
| J9267 |
Injection, paclitaxel, 1 mg |
215 |
135 |
$515.99 |
| 77280 |
|
29 |
25 |
$486.81 |
| J3490 |
Unclassified drugs |
4,599 |
2,926 |
$438.27 |
| 96402 |
|
612 |
579 |
$428.06 |
| 90686 |
|
86 |
86 |
$393.17 |
| 85007 |
|
209 |
207 |
$363.22 |
| J9171 |
Injection, docetaxel, 1 mg |
33 |
25 |
$343.28 |
| 85610 |
|
1,404 |
1,172 |
$327.63 |
| 88184 |
|
118 |
114 |
$295.26 |
| 83010 |
|
303 |
294 |
$279.64 |
| 84436 |
|
626 |
616 |
$244.04 |
| 82105 |
|
406 |
377 |
$168.42 |
| 98967 |
|
19 |
19 |
$141.11 |
| J9201 |
Injection, gemcitabine hydrochloride, not otherwise specified, 200 mg |
15 |
12 |
$125.62 |
| J1644 |
Injection, heparin sodium, per 1000 units |
509 |
318 |
$115.28 |
| G2211 |
Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's single, serious condition or a complex condition. (add-on code, list separately in addition to office/outpatient evaluation and management visit, new or established) |
876 |
838 |
$114.27 |
| 84439 |
|
137 |
129 |
$105.97 |
| 99490 |
Ccm add 20min |
40 |
40 |
$103.95 |
| 84481 |
|
67 |
62 |
$88.40 |
| 90471 |
|
312 |
311 |
$76.27 |
| 82977 |
|
109 |
107 |
$72.07 |
| 90688 |
|
88 |
87 |
$66.90 |
| 85730 |
|
158 |
157 |
$62.87 |
| 85651 |
|
314 |
305 |
$56.53 |
| 84550 |
|
275 |
248 |
$54.14 |
| 99459 |
|
43 |
43 |
$45.63 |
| 84153 |
|
71 |
64 |
$44.13 |
| 86301 |
|
66 |
54 |
$33.28 |
| 77332 |
|
12 |
12 |
$32.23 |
| J7040 |
Infusion, normal saline solution, sterile (500 ml = 1 unit) |
212 |
175 |
$28.47 |
| J3475 |
Injection, magnesium sulfate, per 500 mg |
40 |
24 |
$23.83 |
| 84100 |
|
140 |
132 |
$11.79 |
| 90756 |
|
165 |
165 |
$7.00 |
| 85652 |
|
65 |
65 |
$2.41 |
| S0028 |
Injection, famotidine, 20 mg |
76 |
49 |
$0.98 |
| 97110 |
|
31 |
12 |
$0.00 |
| 90662 |
|
26 |
26 |
$0.00 |
| 99443 |
|
17 |
16 |
$0.00 |
| J2997 |
Injection, alteplase recombinant, 1 mg |
81 |
68 |
$0.00 |
| J3590 |
Unclassified biologics |
13 |
12 |
$0.00 |
| 80050 |
|
14 |
14 |
$0.00 |
| J1720 |
Injection, hydrocortisone sodium succinate, up to 100 mg |
27 |
24 |
$0.00 |
| 36591 |
|
30 |
25 |
$0.00 |
| G0008 |
Administration of influenza virus vaccine |
31 |
31 |
$0.00 |
| 97140 |
|
31 |
12 |
$0.00 |